TCRR
TCR2 Therapeutics Inc
Price:  
1.48 
USD
Volume:  
3,913,310.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TCRR Intrinsic Value

-1,503.43 %
Upside

What is the intrinsic value of TCRR?

As of 2025-06-20, the Intrinsic Value of TCR2 Therapeutics Inc (TCRR) is -20.77 USD. This TCRR valuation is based on the model Peter Lynch Fair Value. With the current market price of 1.48 USD, the upside of TCR2 Therapeutics Inc is -1,503.43%.

Is TCRR undervalued or overvalued?

Based on its market price of 1.48 USD and our intrinsic valuation, TCR2 Therapeutics Inc (TCRR) is overvalued by 1,503.43%.

Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.

1.48 USD
Stock Price
-20.77 USD
Intrinsic Value
Intrinsic Value Details

TCRR Intrinsic Value - Valuation Summary

Range Selected Upside
a
Fair Value -20.77 - -20.77 -20.77 -1,503.43%
P/E (53.17) - (108.01) (80.07) -5510.2%
DDM - Stable (27.51) - (66.40) (46.95) -3272.6%
DDM - Multi (21.75) - (41.59) (28.64) -2035.1%

TCRR Intrinsic Value - Key Valuation Metrics

Market Cap (mil) 58.11
Beta 1.05
Outstanding shares (mil) 39.26
Enterprise Value (mil) 43.66
Market risk premium 4.60%
Cost of Equity 12.10%
Cost of Debt 5.00%
WACC 8.55%